NCT01644591 - Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain Metastases | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 2, 2012

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions

Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Neoplasm in the BrainMetastatic MelanomaPathologic Stage IV Cutaneous Melanoma AJCC v8

Interventions

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

RADIATION

Stereotactic Radiosurgery

Undergo SRS

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER